Description
A selective, competitive, and highly bioavailable inhibitor of L-PGDS (Ki = 75 µM); inhibits the production of PGD2 by L-PGDS-expressing cells purified from human CSF and recombinant mouse with an IC50 value of 95 µM
Formal name: 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine
Synonyms:
Molecular weight: 397.5
CAS: 162640-98-4
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Prostaglandin Synthases||Research Area|Immunology & Inflammation|Allergy||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Immunology & Inflammation|Innate Immunity